arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

PLUS THERAPEUTICS, INC.

PSTV

$3.87 0.00 (0.00%) at close

18 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

PLUS THERAPEUTICS, INC. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $12.0M

Dividend Yield —

Revenue Growth -10.5% ↘

Op. Margin -293.5% ↘

ROIC -382.8% ↘

FCF / Share $-6.70 ↗

Trailing P/E —

Price / Book 5.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Jul 31, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$5.21M

↓ -10.5% —

Net Income Profit after all expenses

$-22.39M

↓ -72.5% —

Operating Margin Operating profit as % of sales

-293.5%

↓ -16.3% 0th

FCF / Share Free cash flow per share

$-6.70

↑ +83.4% —

Long-Term Debt Long-term obligations

$3.79M

↓ -24.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	-10.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-231%)	18.5% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+132%)	—	—	—	—	—	36.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+356%)	-42.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-628%)	-3.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-147%)	-2.3% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-129%)	-30.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-481%)	-18.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-328%)	9.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+14%)	-3.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-141%)	41.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+418%)	—	—
EPS Growth YoY (%)	85.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	54.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	63.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	37.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-72.5% Weak ↓ Weak Declining Year-over-year change in net income	2.5% Caution ↑ Caution Improving Year-over-year change in net income	34.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-51.3% Weak ↓ Weak Declining Year-over-year change in net income	-62.6% Weak ↓ Weak Declining Year-over-year change in net income	24.3% Good ↑ Good Improving Year-over-year change in net income	13.8% Fair ↑ Fair Improving Year-over-year change in net income	44.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-2.9% Weak ↑ Weak Improving Year-over-year change in net income	-17.6% Weak ↓ Weak Declining Year-over-year change in net income	49.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-42.8% Weak ↓ Weak Declining Year-over-year change in net income	18.9% Good ↑ Good Improving Year-over-year change in net income	0.5% Caution ↑ Caution Improving Year-over-year change in net income	-18.0% Weak Weak Year-over-year change in net income	-18.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	83.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	61.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	44.1% Excellent Excellent Year-over-year change in free cash flow	47.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	-8.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-18.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-13.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-17.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-14.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-4.8% Weak Weak Compound annual revenue growth over 3 years	14.3% Good Good Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	—	6.0% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	-12.4% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-20.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-10.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-10.1% Weak Weak Compound annual revenue growth over 5 years	-3.2% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	-293.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2056%)	-252.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1782%)	-271.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1908%)	—	—	—	—	-345.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2406%)	—	-423.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2922%)	-316.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2206%)	—	-430.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2972%)	-326.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2275%)	-368.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2556%)	-306.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2145%)	-369.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2561%)	—
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-429.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3679%)	-222.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1957%)	-271.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2359%)	—	—	—	—	-344.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2968%)	—	-473.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4046%)	-387.4% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3329%)	—	-367.6% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3163%)	-370.6% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3189%)	-406.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3488%)	-333.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2876%)	-397.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3414%)	—
FCF Margin (%) (%)	-399.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-183.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-264.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	-326.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	-383.5% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-449.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-293.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-411.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	1.03x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-382.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	164.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	780.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-152.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-62.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-249.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-249.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-192.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-125.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-141.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-98.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	449.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-773.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-347.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-233.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-87.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	465.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-93.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-221.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-117.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-82.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-56.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-79.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-52.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-65.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-56.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-83.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-72.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-65.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-38.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	—	145.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+867%)	—	—	-123.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-924%)	-271.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1913%)	—	-241.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1712%)	-174.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1263%)	-200.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1438%)	-153.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1124%)	—	—	—	—	-120.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-901%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	—	—	—	0.59x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.46x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-23%)	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	-459.22x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-60.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-27.72x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.66x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.97x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.61x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.09x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.42x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.03x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.39x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.34x Weak Weak Operating income divided by interest expense Optimal: > 5x	-15.10x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-4.26M	$-76.00K	$-8.55M	$-14.33M	$-13.39M	$-8.35M	$-17.55M	$-5.26M	$-9.55M	$-12.56M	$-14.34M	$-14.62M	$-15.51M	$-25.72M	$-36.92M	$-52.67M	$-12.85M	$-12.61M
Debt / EBITDA (x)	—	—	—	-0.20x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.41x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$1.68	$21.93	$39.10	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-7.25	$-48.75	$-106.00	$-289.50	$-462.50	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-6.70	$-40.28	$-103.56	$-185.28	$-354.31	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.72	$-37.94	$-7.58	$71.93	$291.10	$187.13	$124.55	—	—	—	—	$-797.14	$610.05	$1.36K	$2.44K	$6.11K	—	—
Tangible Book Value per Share (USD)	$0.65	$-39.52	$-9.68	$67.78	$281.11	$164.16	$84.61	—	$6.74K	—	—	$-2.66K	$-1.97K	$533.73	$1.43K	$4.96K	—	—
Basic Weighted Avg Shares (shares)	3.11M	265,610	125,637	70,014	29,014	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$2.86M	$-10.29M	$-893.00K	$9.96M	$13.85M	$636.00K	$5.34M	$-7.91M	$-3.55M	$6.25M	$12.81M	$5.77M	$9.67M	$16.37M	$35.52M	$45.73M	—	—
LT Debt (USD)	—	—	—	$3.79M	$5.00M	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$4.00M	$-8.95M	$-1.35M	$6.45M	$10.84M	$3.03M	$1.16M	$5.22M	$13.00M	$10.99M	$12.21M	$-5.70M	$3.13M	$6.46M	$9.95M	$22.87M	$-3.66M	$-7.72M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$5.21M	$5.82M	$4.91M	—	—	—	—	$3.67M	$2.69M	$4.66M	$4.84M	$4.95M	$7.12M	$8.71M	$7.98M	$8.25M	$5.84M	—
Depreciation Expense (USD)	$445.00K	$872.00K	$628.00K	$619.00K	$395.00K	$366.00K	$896.00K	$2.00M	$2.15M	$1.18M	$1.09M	$779.00K	$1.63M	$933.00K	$855.00K	$931.00K	$1.68M	—
Net Income, GAAP (USD)	$-22.39M	$-12.98M	$-13.32M	$-20.27M	$-13.40M	$-8.24M	$-10.89M	$-12.63M	$-22.69M	$-22.05M	$-18.74M	$-37.37M	$-26.18M	$-32.28M	$-32.45M	$-27.49M	$-23.22M	—
Operating Cash Flow (USD)	$-20.77M	$-10.55M	$-12.85M	$-12.97M	$-10.28M	$-8.43M	$-5.91M	$-11.97M	$-18.13M	—	—	—	—	$-32.19M	$-35.32M	$-23.57M	$-23.81M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

PLUS THERAPEUTICS, INC.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PSTV with peers